News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Nicholas Dadarino: The immune landscape of recurrent GBM
Nov 14, 2024, 16:03

Nicholas Dadarino: The immune landscape of recurrent GBM

Nicholas Dadarino, Neurosurgery Research Fellow at Columbia Neurosurgery, shared on X:

“Excited to share our team’s recent paper on the immune landscape of recurrent GBM. We dive into the complex role of glioma-associated microglia and macrophages (GAMMs) in shaping the tumor microenvironment, with histological insights for targeted therapies.”

Nicolas Dadarino

Unveiling the Inflammatory Landscape of Recurrent Glioblastoma through Histological-Based Assessments

Authors: Nicholas B. Dadario, Deborah M. Boyett, Damian E. Teasley, Peter J. Chabot, Nathan J. Winans, Michael G. Argenziano, Colin P. Sperring,Peter Canoll, Jeffrey N. Bruce

Nicholas Dadarino: The immune landscape of recurrent GBM

Nicholas Dadario is a Neurosurgery Research Fellow at Columbia Neurosurgery and an MD candidate (2025) at Rutgers Robert Wood Johnson Medical School. His work focuses on advancing neurosurgical care through innovative technology and advanced statistical modeling, utilizing tractography and parcellation-based analyses to study brain network connectivity and its functional and clinical impacts.

 

cancer Colin P. Sperring Damian E. Teasley Deborah M. Boyett Jeffrey N. Bruce Michael G. Argenziano Nathan J. Winans Nicholas B. Dadario Nicolas Dadarino OncoDaily Oncology Peter Canoll Peter J. Chabot
Special Coverage
Career
Dec 23, 2024, 06:28
Fadi Haddad: Elise Nassif Haddad received the Rising Star Award for Excellence in Clinical Care
Insight
Dec 23, 2024, 06:21
Drew Moghanaki: The largest randomized phase III trial evaluating lung SBRT
Science
Dec 23, 2024, 06:08
Emanuele Crupi: N4 appears to be far more complex than we initially imagined
Blog
Dec 23, 2024, 06:05
Eric Singhi: Naveen Pemmaraju was named FY24 Fastest PI at MD Anderson DoCM
Blog
Dec 23, 2024, 06:00
Anirban Maitra: Targeting the PI3Ka-RAS interaction axis
Blog
Dec 23, 2024, 05:56
Megan-Claire Chase: The different layers of advocacy, both in the public eye and behind the scenes
Blog
Dec 23, 2024, 05:49
Shikha Jain: From Burnout to Breakthrough - How These Entrepreneurs Are Empowering Women in Healthcare
Blog
Dec 23, 2024, 05:43
Pashtoon Kasi: City of Hope Buys 52 Acres in Orange County for $89M
Blog
Dec 23, 2024, 05:31
The Leukemia Lymphoma Society - Give today for a brighter tomorrow for those affected by Blood Cancer
Blog
Dec 22, 2024, 18:02
Erman Akkus: Negative hyper-selection for anti-EGFR therapy in mCRC
Insight
Dec 22, 2024, 17:57
Gustavo Viani: Internal Mammary Node Radiation, A Survival Boost for Breast Cancer Patients?
Insight
Dec 22, 2024, 17:54
Stephen Liu: The seminal IPASS trial in EGFR NSCLC